Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Pechala's Reports
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Synergy Pharmaceuticals Inc Announces Public Offering of Common Stock


Tuesday, 9 Apr 2013 04:35pm EDT 

Synergy Pharmaceuticals Inc announced that it is offering to sell an aggregate value of $90,000,000 of its common stock in an underwritten public offering (or an aggregate value of $103,500,000 of its common stock if the underwriters of such offering exercise their over-allotment option in full). Credit Suisse, Citigroup and Canaccord Genuity are acting as book-running managers in this offering. 

Company Quote

3.01
-0.06 -1.95%
27 Jan 2015